{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:30:42Z","timestamp":1776205842072,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Glioma is a malignant brain tumor with a high mortality rate; hence novel treatment approaches are being explored to improve patient outcomes. Ferroptosis, a newly described form of regulated cell death, is emerging as a potential therapeutic target in glioma. Ferroptosis is characterized by the accumulation of lipid peroxides due to a loss of intracellular antioxidant systems represented by the depletion of glutathione and decreased activity of glutathione peroxidase 4 (GPX4). Since glioma cells have a high demand for iron and lipid metabolism, modulation of ferroptosis may represent a promising therapeutic approach for this malignancy. Recent studies indicate that ferroptosis inducers like erastin and RSL3 display potent anticancer activity in a glioma model. In addition, therapeutic strategies, including GPX4 targeting, lipid metabolism modulation, inhibition of amino acid transporters, and ferroptosis targeting natural compounds, have shown positive results in preclinical studies. This review will provide an overview of the functions of ferroptosis in glioma and its potential as a suitable target for glioma therapy.<\/jats:p>","DOI":"10.3389\/fneur.2023.1292160","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T03:24:35Z","timestamp":1699327475000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel approaches targeting ferroptosis in treatment of glioma"],"prefix":"10.3389","volume":"14","author":[{"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengling","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengzhe","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.soncn.2018.10.001","article-title":"Epidemiology and overview of gliomas","volume":"34","author":"Davis","year":"2018","journal-title":"Semin Oncol Nurs"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"703764","DOI":"10.3389\/fonc.2021.703764","article-title":"Uncovering spatiotemporal heterogeneity of high-grade gliomas: from disease biology to therapeutic implications","volume":"11","author":"Comba","year":"2021","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040937","article-title":"Glioblastoma: pathogenesis and current status of chemotherapy and other novel treatments","volume":"12","author":"Rajaratnam","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3389\/fonc.2019.00506","article-title":"Isocitrate dehydrogenase mutations in glioma: from basic discovery to therapeutics development","volume":"9","author":"Huang","year":"2019","journal-title":"Front Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215362","article-title":"TP53 mutation is a prognostic factor in lower grade glioma and may influence chemotherapy efficacy","volume":"13","author":"Noor","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/14728222.2018.1487953","article-title":"Mutant ATRX: uncovering a new therapeutic target for glioma","volume":"22","author":"Haase","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020587","article-title":"Updated insights on EGFR signaling pathways in glioma","volume":"22","author":"Oprita","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.2147\/OTT.S99942","article-title":"PTEN gene mutations correlate to poor prognosis in glioma patients: a meta-analysis","volume":"9","author":"Han","year":"2016","journal-title":"Onco Targets Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41374-022-00741-7","article-title":"The epigenetic dysfunction underlying malignant glioma pathogenesis","volume":"102","author":"Dharmaiah","year":"2022","journal-title":"Lab Investig"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2174\/0929867323666161223150242","article-title":"Recent advances in targeted therapy for glioma","volume":"24","author":"Lin","year":"2017","journal-title":"Curr Med Chem"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","article-title":"Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study","volume":"27","author":"Mohammed","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/08830185.2021.2016739","article-title":"Molecular mechanisms of ferroptosis and their role in inflammation","volume":"42","author":"Wang","year":"2023","journal-title":"Int Rev Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"974156","DOI":"10.3389\/fmolb.2022.974156","article-title":"Emerging role of ferroptosis in glioblastoma: therapeutic opportunities and challenges","volume":"9","author":"Zhuo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41419-022-05044-9","article-title":"High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1\/MRP1 upregulation","volume":"13","author":"De Souza","year":"2022","journal-title":"Cell Death Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41467-023-36630-w","article-title":"Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism","volume":"14","author":"Upadhyayula","year":"2023","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112123","article-title":"Ferroptosis and its potential role in glioma: from molecular mechanisms to therapeutic opportunities","volume":"11","author":"Luo","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0281840","DOI":"10.1371\/journal.pone.0281840","article-title":"Oncometabolic role of mitochondrial sirtuins in glioma patients","volume":"18","author":"Haq","year":"2023","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11060-020-03527-3","article-title":"Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models","volume":"148","author":"Ni","year":"2020","journal-title":"J Neuro-Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0182954","DOI":"10.1371\/journal.pone.0182954","article-title":"Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: expression and prognostic value","volume":"12","author":"Rosager","year":"2017","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1541-7786.MCR-16-0028","article-title":"Increased expression of system xc- in glioblastoma confers an altered metabolic state and Temozolomide resistance","volume":"14","author":"Polewski","year":"2016","journal-title":"Mol Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1158\/0008-5472.CAN-15-2121","article-title":"The EGF receptor promotes the malignant potential of glioma by regulating amino acid transport system xc(\u2212)","volume":"76","author":"Tsuchihashi","year":"2016","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","article-title":"System X(c) (\u2212)\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"216119","DOI":"10.1016\/j.canlet.2023.216119","article-title":"Targeting GPX4 in human cancer: implications of ferroptosis induction for tackling cancer resilience","volume":"559","author":"Lee","year":"2023","journal-title":"Cancer Lett"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2915019","article-title":"RSL3 drives Ferroptosis through NF-kappa B pathway activation and GPX4 depletion in glioblastoma","volume":"2021","author":"Li","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1107\/S2059798320016125","article-title":"Crystal structures of the selenoprotein glutathione peroxidase 4 in its apo form and in complex with the covalently bound inhibitor ML162","volume":"77","author":"Moosmayer","year":"2021","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41419-021-04306-2","article-title":"Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.7150\/jca.58500","article-title":"FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma","volume":"12","author":"Zhang","year":"2021","journal-title":"J Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"913669","DOI":"10.3389\/fonc.2022.913669","article-title":"Glutathione peroxidase 4 as a therapeutic target for anti-colorectal Cancer drug-tolerant Persister cells","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2023.05.035","article-title":"Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma","volume":"359","author":"Zhao","year":"2023","journal-title":"J Control Release"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nchembio.2079","article-title":"Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis","volume":"12","author":"Shimada","year":"2016","journal-title":"Nat Chem Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071391","article-title":"New insights on the uptake and trafficking of coenzyme Q","volume":"12","author":"Guile","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2022.10.017","article-title":"18beta-glycyrrhetinic acid protects neuronal cells from ferroptosis through inhibiting labile iron accumulation and preventing coenzyme Q10 reduction","volume":"635","author":"Ma","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2023.05.003","article-title":"Regulation of ferroptosis by lipid metabolism","author":"Pope","year":"2023","journal-title":"Trends Cell Biol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/or.2019.7419","article-title":"ACSL4 suppresses glioma cells proliferation via activating ferroptosis","volume":"43","author":"Cheng","year":"2020","journal-title":"Oncol Rep"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3389\/fphar.2017.00960","article-title":"SCD1 confers Temozolomide resistance to human glioma cells via the Akt\/GSK3beta\/beta-catenin signaling Axis","volume":"8","author":"Dai","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"174860","DOI":"10.1016\/j.ejphar.2022.174860","article-title":"Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway","volume":"921","author":"Chen","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"43408","DOI":"10.1021\/acsami.0c12042","article-title":"Glioblastoma therapy using Codelivery of cisplatin and glutathione peroxidase targeting siRNA from Iron oxide nanoparticles","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e2206333","DOI":"10.1002\/advs.202206333","article-title":"A brain-targeting NIR-II Ferroptosis system: effective visualization and oncotherapy for Orthotopic glioblastoma","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ddr.21557","article-title":"Novel analogs of sulfasalazine as system x(c)(\u2212) antiporter inhibitors: insights from the molecular modeling studies","volume":"80","author":"Patel","year":"2019","journal-title":"Drug Dev Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28124643","article-title":"Terpinen-4-ol induces Ferroptosis of glioma cells via downregulating JUN proto-oncogene","volume":"28","author":"Cao","year":"2023","journal-title":"Molecules"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"101413","DOI":"10.1016\/j.redox.2019.101413","article-title":"AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-mediated redox homeostasis","volume":"30","author":"Chen","year":"2020","journal-title":"Redox Biol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/tox.23662","article-title":"The dual role of boron in vitro neurotoxication of glioblastoma cells via SEMA3F\/NRP2 and ferroptosis signaling pathways","volume":"38","author":"Kar","year":"2023","journal-title":"Environ Toxicol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193314","article-title":"Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition","volume":"40","author":"Yi","year":"2020","journal-title":"Biosci Rep"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12032-023-02095-6","article-title":"Fucoxanthin triggers ferroptosis in glioblastoma cells by stabilizing the transferrin receptor","volume":"40","author":"Zhu","year":"2023","journal-title":"Med Oncol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"154693","DOI":"10.1016\/j.prp.2023.154693","article-title":"Unveiling the therapeutic potential of natural-based anticancer compounds inducing non-canonical cell death mechanisms","volume":"248","author":"Bozgeyik","year":"2023","journal-title":"Pathol Res Pract"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1292160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T03:24:37Z","timestamp":1699327477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1292160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":49,"alternative-id":["10.3389\/fneur.2023.1292160"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1292160","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"article-number":"1292160"}}